药理学方法对有症状的不持续的风性心跳动
Ida Obeso-Martinez1, Farshad Raissi
1Author Affiliations: University of San Diego, San Diego, California (Dr Colio); Imperial Cardiac Center, Imperial, California (Dr Obeso-Martinez); and University of California San Diego, San Diego (Dr Raissi).
Advanced emergency nursing journal
|May 13, 2024
概括
不持续的腹腔动脉高心率 (NSVT) 是一种常见的心律问题. 本案例讨论了其在稳定患者中的典型表现和治疗.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 非持续性心室低心率 (NSVT) 是一种常见的心律失常,与心力衰竭和冠状动脉疾病等各种心脏疾病有关.
- 虽然NSVT往往无症状,但可以表现为心,近同步,头,胸痛和呼吸障碍等症状.
研究的目的:
- 详细介绍稳定的NSVT的常见临床表现.
- 概述诊断为稳定NSVT的患者的药理管理策略.
主要方法:
- 诊断往往需要长时间的心脏监测,移动心脏遥测 (MCT) 或内部循环记录器,因为标准心电图在急诊室 (ED) 抵达时可能无法捕捉心律失常.
- 案例研究方法侧重于典型的患者表现和随后的治疗.
主要成果:
- 由于间歇性质,NSVT诊断可能具有挑战性,通常需要超出初始心电图的高级监测.
- 在一些NSVT病例中,由于需求缺血,可以出现升的热素水平.
结论:
- 有效识别NSVT依赖于扩展的心脏监测.
- 药理干预是管理稳定的NSVT表现的关键.
相关概念视频
Disturbances in Heart Rhythm
945
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
945
Increased pulse rate
657
Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
657
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
740
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
740
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
830
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
830
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
978
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
978
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K


